(AU) AngloGold Ashanti - Overview
Exchange: NYSE •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US0351282068
Stock: Gold, Silver, Sulphuric Acid
Total Rating 63
Risk 84
Buy Signal -1.53
| Risk 5d forecast | |
|---|---|
| Volatility | 65.6% |
| Relative Tail Risk | -2.42% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.66 |
| Alpha | 123.66 |
| Character TTM | |
|---|---|
| Beta | 0.645 |
| Beta Downside | 0.672 |
| Drawdowns 3y | |
|---|---|
| Max DD | 48.33% |
| CAGR/Max DD | 1.20 |
EPS (Earnings per Share)
Revenue
Description: AU AngloGold Ashanti March 05, 2026
AngloGold Ashanti plc (AU) is a gold mining company with operations across Africa, Australia, and the Americas. The companys primary focus is gold exploration, but it also extracts by-products such as silver and sulphuric acid. Gold mining companies often diversify their revenue streams through such by-products.
Its key asset is the 100% owned Geita mine in Tanzania. AngloGold Ashanti plc was founded in 1944 and is headquartered in Greenwood Village, Colorado. Understanding a companys operational footprint and history can provide valuable context for further research on platforms like ValueRay.
Headlines to watch out for
- Global gold price fluctuations impact revenue
- Production costs influenced by energy and labor expenses
- Regulatory changes in mining jurisdictions affect operations
- Geopolitical stability in operating regions impacts output
Piotroski VR‑10 (Strict, 0-10) 8.0
| Net Income: 2.64b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.20 > 0.02 and ΔFCF/TA 15.12 > 1.0 |
| NWC/Revenue: 30.60% < 20% (prev 30.59%; Δ 0.00% < -1%) |
| CFO/TA 0.31 > 3% & CFO 4.68b > Net Income 2.64b |
| Net Debt (-492.0m) to EBITDA (4.51b): -0.11 < 3 |
| Current Ratio: 2.87 > 1.5 & < 3 |
| Outstanding Shares: last quarter (508.9m) vs 12m ago 11.53% < -2% |
| Gross Margin: 48.33% > 18% (prev 0.34%; Δ 4.80k% > 0.5%) |
| Asset Turnover: 70.08% > 50% (prev 42.43%; Δ 27.64% > 0%) |
| Interest Coverage Ratio: 7.79 > 6 (EBITDA TTM 4.51b / Interest Expense TTM 220.0m) |
Altman Z'' 5.41
| A: 0.20 (Total Current Assets 4.65b - Total Current Liabilities 1.62b) / Total Assets 15.08b |
| B: 0.50 (Retained Earnings 7.54b / Total Assets 15.08b) |
| C: 0.12 (EBIT TTM 1.71b / Avg Total Assets 14.12b) |
| D: 1.57 (Book Value of Equity 8.09b / Total Liabilities 5.16b) |
| Altman-Z'' Score: 5.41 = AAA |
Beneish M -3.53
| DSRI: 0.13 (Receivables 136.0m/571.0m, Revenue 9.89b/5.58b) |
| GMI: 0.71 (GM 48.33% / 34.43%) |
| AQI: 1.10 (AQ_t 0.11 / AQ_t-1 0.10) |
| SGI: 1.77 (Revenue 9.89b / 5.58b) |
| TATA: -0.14 (NI 2.64b - CFO 4.68b) / TA 15.08b) |
| Beneish M-Score: -3.53 (Cap -4..+1) = AAA |
What is the price of AU shares?
As of March 22, 2026, the stock is trading at USD 79.99 with a total of 6,978,309 shares traded.
Over the past week, the price has changed by -15.70%, over one month by -28.81%, over three months by -9.63% and over the past year by +129.12%.
Over the past week, the price has changed by -15.70%, over one month by -28.81%, over three months by -9.63% and over the past year by +129.12%.
Is AU a buy, sell or hold?
AngloGold Ashanti has received a consensus analysts rating of 3.38.
Therefor, it is recommend to hold AU.
- StrongBuy: 1
- Buy: 3
- Hold: 3
- Sell: 0
- StrongSell: 1
What are the forecasts/targets for the AU price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 126.4 | 58.1% |
| Analysts Target Price | 126.4 | 58.1% |
AU Fundamental Data Overview March 19, 2026
P/E Trailing = 18.5356
P/E Forward = 11.4679
P/S = 4.9108
P/B = 6.0045
P/EG = 0.782
Revenue TTM = 9.89b USD
EBIT TTM = 1.71b USD
EBITDA TTM = 4.51b USD
Long Term Debt = 2.02b USD (from longTermDebt, two quarters ago)
Short Term Debt = 101.0m USD (from shortTermDebt, last quarter)
Debt = 2.44b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -492.0m USD (from netDebt column, last quarter)
Enterprise Value = 48.09b USD (48.58b + Debt 2.44b - CCE 2.93b)
Interest Coverage Ratio = 7.79 (Ebit TTM 1.71b / Interest Expense TTM 220.0m)
EV/FCF = 15.60x (Enterprise Value 48.09b / FCF TTM 3.08b)
FCF Yield = 6.41% (FCF TTM 3.08b / Enterprise Value 48.09b)
FCF Margin = 31.17% (FCF TTM 3.08b / Revenue TTM 9.89b)
Net Margin = 26.65% (Net Income TTM 2.64b / Revenue TTM 9.89b)
Gross Margin = 48.33% ((Revenue TTM 9.89b - Cost of Revenue TTM 5.11b) / Revenue TTM)
Gross Margin QoQ = 50.62% (prev 49.32%)
Tobins Q-Ratio = 3.19 (Enterprise Value 48.09b / Total Assets 15.08b)
Interest Expense / Debt = 2.22% (Interest Expense 54.0m / Debt 2.44b)
Taxrate = 29.99% (433.0m / 1.44b)
NOPAT = 1.20b (EBIT 1.71b * (1 - 29.99%))
Current Ratio = 2.87 (Total Current Assets 4.65b / Total Current Liabilities 1.62b)
Debt / Equity = 0.30 (Debt 2.44b / totalStockholderEquity, last quarter 8.09b)
Debt / EBITDA = -0.11 (Net Debt -492.0m / EBITDA 4.51b)
Debt / FCF = -0.16 (Net Debt -492.0m / FCF TTM 3.08b)
Total Stockholder Equity = 7.49b (last 4 quarters mean from totalStockholderEquity)
RoA = 18.67% (Net Income 2.64b / Total Assets 15.08b)
RoE = 35.18% (Net Income TTM 2.64b / Total Stockholder Equity 7.49b)
RoCE = 18.00% (EBIT 1.71b / Capital Employed (Equity 7.49b + L.T.Debt 2.02b))
RoIC = 12.77% (NOPAT 1.20b / Invested Capital 9.39b)
WACC = 7.97% (E(48.58b)/V(51.02b) * Re(8.29%) + D(2.44b)/V(51.02b) * Rd(2.22%) * (1-Tc(0.30)))
Discount Rate = 8.29% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 9.90%
[DCF] Terminal Value 70.37% ; FCFF base≈2.13b ; Y1≈1.40b ; Y5≈638.3m
[DCF] Fair Price = 25.83 (EV 12.55b - Net Debt -492.0m = Equity 13.04b / Shares 505.0m; r=7.97% [WACC]; 5y FCF grow -40.0% → 2.90% )
EPS Correlation: 69.55 | EPS CAGR: 59.49% | SUE: 0.0 | # QB: 0
Revenue Correlation: 75.97 | Revenue CAGR: 33.03% | SUE: 0.10 | # QB: 0
EPS next Quarter (2026-06-30): EPS=2.17 | Chg7d=+0.075 | Chg30d=-0.020 | Revisions Net=-1 | Analysts=2
EPS current Year (2026-12-31): EPS=9.74 | Chg7d=+0.487 | Chg30d=+0.828 | Revisions Net=+2 | Growth EPS=+81.4% | Growth Revenue=+42.4%
EPS next Year (2027-12-31): EPS=9.70 | Chg7d=+0.742 | Chg30d=+0.525 | Revisions Net=+3 | Growth EPS=-0.4% | Growth Revenue=+3.7%
[Analyst] Revisions Ratio: -1.00 (0 Up / 1 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 2.9% (Discount Rate 8.3% - Earnings Yield 5.4%)
[Growth] Growth Spread = +19.9% (Analyst 22.8% - Implied 2.9%)
P/E Forward = 11.4679
P/S = 4.9108
P/B = 6.0045
P/EG = 0.782
Revenue TTM = 9.89b USD
EBIT TTM = 1.71b USD
EBITDA TTM = 4.51b USD
Long Term Debt = 2.02b USD (from longTermDebt, two quarters ago)
Short Term Debt = 101.0m USD (from shortTermDebt, last quarter)
Debt = 2.44b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -492.0m USD (from netDebt column, last quarter)
Enterprise Value = 48.09b USD (48.58b + Debt 2.44b - CCE 2.93b)
Interest Coverage Ratio = 7.79 (Ebit TTM 1.71b / Interest Expense TTM 220.0m)
EV/FCF = 15.60x (Enterprise Value 48.09b / FCF TTM 3.08b)
FCF Yield = 6.41% (FCF TTM 3.08b / Enterprise Value 48.09b)
FCF Margin = 31.17% (FCF TTM 3.08b / Revenue TTM 9.89b)
Net Margin = 26.65% (Net Income TTM 2.64b / Revenue TTM 9.89b)
Gross Margin = 48.33% ((Revenue TTM 9.89b - Cost of Revenue TTM 5.11b) / Revenue TTM)
Gross Margin QoQ = 50.62% (prev 49.32%)
Tobins Q-Ratio = 3.19 (Enterprise Value 48.09b / Total Assets 15.08b)
Interest Expense / Debt = 2.22% (Interest Expense 54.0m / Debt 2.44b)
Taxrate = 29.99% (433.0m / 1.44b)
NOPAT = 1.20b (EBIT 1.71b * (1 - 29.99%))
Current Ratio = 2.87 (Total Current Assets 4.65b / Total Current Liabilities 1.62b)
Debt / Equity = 0.30 (Debt 2.44b / totalStockholderEquity, last quarter 8.09b)
Debt / EBITDA = -0.11 (Net Debt -492.0m / EBITDA 4.51b)
Debt / FCF = -0.16 (Net Debt -492.0m / FCF TTM 3.08b)
Total Stockholder Equity = 7.49b (last 4 quarters mean from totalStockholderEquity)
RoA = 18.67% (Net Income 2.64b / Total Assets 15.08b)
RoE = 35.18% (Net Income TTM 2.64b / Total Stockholder Equity 7.49b)
RoCE = 18.00% (EBIT 1.71b / Capital Employed (Equity 7.49b + L.T.Debt 2.02b))
RoIC = 12.77% (NOPAT 1.20b / Invested Capital 9.39b)
WACC = 7.97% (E(48.58b)/V(51.02b) * Re(8.29%) + D(2.44b)/V(51.02b) * Rd(2.22%) * (1-Tc(0.30)))
Discount Rate = 8.29% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 9.90%
[DCF] Terminal Value 70.37% ; FCFF base≈2.13b ; Y1≈1.40b ; Y5≈638.3m
[DCF] Fair Price = 25.83 (EV 12.55b - Net Debt -492.0m = Equity 13.04b / Shares 505.0m; r=7.97% [WACC]; 5y FCF grow -40.0% → 2.90% )
EPS Correlation: 69.55 | EPS CAGR: 59.49% | SUE: 0.0 | # QB: 0
Revenue Correlation: 75.97 | Revenue CAGR: 33.03% | SUE: 0.10 | # QB: 0
EPS next Quarter (2026-06-30): EPS=2.17 | Chg7d=+0.075 | Chg30d=-0.020 | Revisions Net=-1 | Analysts=2
EPS current Year (2026-12-31): EPS=9.74 | Chg7d=+0.487 | Chg30d=+0.828 | Revisions Net=+2 | Growth EPS=+81.4% | Growth Revenue=+42.4%
EPS next Year (2027-12-31): EPS=9.70 | Chg7d=+0.742 | Chg30d=+0.525 | Revisions Net=+3 | Growth EPS=-0.4% | Growth Revenue=+3.7%
[Analyst] Revisions Ratio: -1.00 (0 Up / 1 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 2.9% (Discount Rate 8.3% - Earnings Yield 5.4%)
[Growth] Growth Spread = +19.9% (Analyst 22.8% - Implied 2.9%)